BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Career Advice

  Interview Insider: Tips on How to Get Hired by Sanofi

  Here are some tips for getting in the door at one of the top international pharmas in the world.

  November 3, 2017

   · 

  5 min read

   · 

  Mark Terry
• Annoroad, a Beijing Gene Services Company, Raises $100M in C Round

  Annoroad raised $100M in a Series C financing, led by SAIF Partners and joined by SBCVC, Shenzhen GTJA Investment Group and Ping An Ventures.

  November 3, 2017

   · 

  1 min read
• 

  Business

  GlaxoSmithKline R&D Chief Jumps Ship for Government Job

  Another top executive at Glaxo is leaving the company as new CEO Emma Walmsley continues to shape the c-suite for her administration.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Booming Drug Sales Make This San Diego Biotech a Prime M&A Target

  Neurocrine’s third-quarter financial results didn’t just impress, they blew everybody away.

  November 3, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  How Gilead Lost $7.8B in October Alone

  Gilead Sciences’ third-quarter financial results were dismal, to say the least.

  November 3, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  This is the Precision Medicine Biotech That’s Revolutionizing Cancer Treatment

  Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.

  November 3, 2017

   · 

  1 min read
• 

  Deals

  Torrent Pharma Coughs Up $558M for Unichem’s India Biz

  The acquisition is expected to close by the end of 2017.

  November 3, 2017

   · 

  1 min read
• 

  Business

  Varian Inks $50M Multi-Year Project Deal

  The company secured a deal to equip Rigshospitalet and Herlev Hospital with modern treatment systems over the next few years.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Mysterious Moderna Hints at Its IPO Timeline

  Moderna CEO said the company was not likely to float its initial public offering until the company has solid data on its lead mRNA treatment.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Intra-Cellular Therapies to Host Third Quarter 2017 Financial Results Conference Call and Webcast

  To access the live conference call via phone, dial 1-(844) 835-6563.

  November 3, 2017

   · 

  1 min read